• UK
    • USA
    • Canada-En
    • Australia
    • Sweden
    • Ireland
    • Norway
    • Intl
    • Belgium-FR
    • Belgium-NL
  • Products
  • Company
  • Support
  • Contact
  • Blog
Logo Logo Logo Logo Logo
  • Independents
  • Chains
  • Labs
  • Independents
  • Chains
  • Labs

07 Apr EFFECTIVE COMMUNICATION: THE KEY TO SUCCESS IN MYOPIA MANAGEMENT – PART 1

Posted at 13:47h in Blog, Thought Leadership by James Loughman

The emergence of new therapies to limit myopia progression offers eyecare practitioners (ECPs) the opportunity to deliver better health outcomes for their patients. Despite growing calls for myopia control to become the new standard of care,(1)uptake of these new treatments by practitioners is still limited....

Read More

16 Aug Managing Myopia: Evolution of a New Standard of Care

Posted at 12:41h in Blog, Thought Leadership by James Loughman

Scientific and industrial innovators have responded to the threat posed by myopia. We now have a rapidly increasing range of treatments available which have been shown to delay myopia onset, reduce or eliminate the progression of myopia in some children and thereby reduce the risk...

Read More

26 Apr The global impact of Covid-19 on eyecare and eye health – Part 2

Posted at 16:03h in Blog, Thought Leadership by James Loughman

According to a recent meta-analysis of published studies, approximately 11% of COVID-19 patients have exhibited direct ocular effects (1). Typically, the complications appear to be relatively mild and short-term. ...

Read More

08 Feb The global impact of Covid-19 on eyecare and eye health – Part 1

Posted at 14:49h in Blog, Thought Leadership by James Loughman

The emergence of the COVID-19 pandemic has had an immediate and dramatic impact on eye care. Even now, more than a year since the emergence of this public health crisis, Covid-19 continues to overwhelm healthcare systems and resources around the globe. T...

Read More

21 Aug PUBLIC HEALTH APPROACHES TO MYOPIA PREVENTION AND CONTROL – PART 2

Posted at 15:21h in Blog, Thought Leadership by James Loughman

We will now examine how a successful public health strategy for myopia might be implemented, and what policy measures might generate sufficient impact to reverse the myopia epidemic....

Read More

06 Aug Public Health approaches to Myopia prevention and control – Part 1

Posted at 12:18h in Blog, Thought Leadership by James Loughman

The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia. ...

Read More

11 Jun Artificial Intelligence and Optometry

Posted at 18:04h in Blog, Thought Leadership by James Loughman

In 20 years, will optometry as we know it exist? Will there be a role for optometry, and how will it be delivered?...

Read More

04 Feb Myopia Control: Every Dioptre Matters

Posted at 11:28h in Blog, Thought Leadership by James Loughman

The global prevalence of myopia has reached unprecedented levels and current projections indicate that about half of the world’s population, 5 billion people, will be myopic by 2050. ...

Read More

20 Nov Defining Pre-Myopia: a new term for an age-old condition

Posted at 16:12h in Blog, Thought Leadership by James Loughman

Over two millennia ago, Aristotle (350BC) first coined the term myopia. He was likely describing the “closed eye” appearance of those squinting as a means to overcome their characteristically impaired distance vision...

Read More
  • 1
  • 2
Ocuco Limited

First Floor
Unit B
Copse Walk
Cardiff Gate Business Park
Cardiff

CF23 8RB
United Kingdom
Tel: 0800 912 1004

Email: info@ocuco.com

Locations around the globe
Links
About Us
Support
Contact Us
Privacy Policy
Sitemap

Ocuco Logo
x

Bienvenue à Ocuco

Entrez le site Web en français

Welkom bij Ocuco

Website in het Nederlands invoeren
  • USA
  • Canada-En
  • UK
  • Australia
  • Sweden
  • Ireland
  • Norway
  • Intl
  • Belgium-FR
  • Belgium-NL
© Copyright Ocuco
This site uses cookies to enhance your experience. By continuing to use the site you accept their use.OkRead more